martes, 4 de febrero de 2020

U.S. officials will let Novartis pay expenses for some Kymriah patients

U.S. officials will let Novartis pay expenses for some Kymriah patients

Cancer Briefing



STAT Plus: U.S. officials will let Novartis pay expenses for some Kymriah patients who must travel for treatment

By ED SILVERMAN


DOMINICK REUTER/AFP/GETTY IMAGES
The decision comes as the federal government is cracking down on drug companies that entice Medicare beneficiaries to use more of their medicines.

No hay comentarios: